FDA approves virtual reality system to ease back pain
Nov 17, 2021
EaseVRx system uses number of cognitive behavioral therapy methods to achieve pain relief
48.3 percent of U.S. population over 16 has at least one dose of COVID-19 vaccine
Jul 15, 2021
As of May 15, 2021, coverage was lower for non-Hispanic Blacks and Hispanics versus Whites; higher for those at risk for severe COVID-19
ADA: Tirzepatide non-inferior, superior to Semaglutide for T2DM
Jun 29, 2021
Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes
Race may impact accuracy of models predicting brain amyloidosis
Apr 25, 2022
Models using plasma Aβ42/Aβ40 to predict probability of CSF Aβ42/Aβ40 positivity not affected by race
Antibody response to SARS-CoV-2 wanes among dialysis patients
Dec 15, 2021
Prebreakthrough index RBD values of <10 and 10 to <23 associated with increased odds of breakthrough infection versus value of ≥23
Pfizer says final data show COVID-19 pill stays strong against severe illness
Dec 14, 2021
Latest results show that drug cuts hospitalizations, deaths by nearly 90 percent when taken within three to five days of the start of symptoms
AAOS: Some seniors may continue opioid use after hip fracture surgery
Sep 02, 2021
Risk factors for persistent opioid use include prior substance abuse, smoking, higher body mass index, fracture fixation surgery
COVID-19 falls from America’s No. 1 killer to No. 7 by June
Jul 01, 2021
(HealthDay News) — A steep rise in vaccination rates has dropped COVID-19 from the first to the seventh leading cause of death in the United States, a new analysis shows. The disease was the third leading...
FDA approves first biosimilar insulin product
Jul 29, 2021
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option
Report shows world ill-prepared for next pandemic
Dec 13, 2021
Preparedness in preventing the emergence of new pathogens was the area with the lowest worldwide score